Epileptic Seizures in Early-onset Multiple Sclerosis

被引:0
|
作者
Etemadifar, Masoud [1 ,2 ]
Abtahi, Seyed-Hossein [1 ,2 ]
Tabrizi, Nasim [1 ,2 ]
机构
[1] Isfahan Univ Med Sci, Dept Neurol, Esfahan, Iran
[2] Isfahan Univ Med Sci, IMSRC, Esfahan, Iran
关键词
Early-onset multiple sclerosis; epileptic seizure; frequency; Isfahan; Iran; CHILDHOOD-ONSET; NATURAL-HISTORY; ISFAHAN; IRAN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early-onset multiple sclerosis (EOMS) is defined as the first presentation of symptoms in childhood (before the age of 16 years). EOMS occurs in about 0.4% to 10.5% of multiple sclerosis (MS) patients. In this retrospective population-based study we aimed to describe the clinical/paraclinical details and frequency of epileptic seizures in Iranian EOMS patients registered with the Isfahan Multiple Sclerosis Society (IMSS) from April 2003 to July 2010. EOMS cases were extracted from the Isfahan total MS cohort and included 3522 patients. A total of 117 EOMS patients (19 males and 98 females) with a mean age at onset of 14.2 +/- 2.0 years (range: 7-16 years) were extracted from our database (3.3% of the total cohort). Of cases, ten (one male and nine females) had experienced at least two epileptic seizures, providing a crude prevalence of 8.5%. The frequency of epilepsy in EOMS patients (8.5%, 10/117) was significantly greater (P < 0.001) than that of non-EOMS cohort (2.0%, 71/3405). Epileptic seizures occurred before MS onset in two patients, after MS onset in seven, and at MS onset in one as the presenting symptom of the disease. Our findings mostly indicate an excessive prevalence of epileptic seizures in Iranian EOMS patients (8.5%), which is higher than any other report concerning seizures or epileptic seizures in a large MS series.
引用
收藏
页码:381 / 383
页数:3
相关论文
共 50 条
  • [41] Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a
    Pakdaman, H.
    Fallah, A.
    Sahraian, M. A.
    Pakdaman, R.
    Meysamie, A.
    NEUROPEDIATRICS, 2006, 37 (04) : 257 - 260
  • [42] Comparing Characteristics of Early-Onset Injection Drug Users to Those With Late-Onset Injection in Kermanshah, Iran
    Shushtari, Zahra Jorjoran
    Noroozi, Alireza
    Mirzazadeh, Ali
    Ahounbar, Elahe
    Hajbi, Ahmad
    Najafi, Mohammad
    Bazrafshan, Ali
    Farhadi, Mohammad Hossin
    Farhoudian, Ali
    Higgs, Peter
    Shahboulagh, Farahnaz Mohammadi
    Waye, Katherine
    Noroozi, Mehdi
    SUBSTANCE USE & MISUSE, 2017, 52 (06) : 754 - 759
  • [43] Pitfalls in Diagnosis of Early-Onset Inflammatory Bowel Disease
    Dore, Mariela
    Triana Junco, Paloma
    Sanchez Galan, Alba
    Prieto, Gerardo
    Ramos, Esther
    Munoz Romo, Martha
    Gomez Cervantes, Manuel
    Hernandez, Francisco
    Martinez, Leopoldo
    Lopez Santamaria, Manuel
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2018, 28 (01) : 39 - 43
  • [44] Early-Onset Takayasu Arteritis in Childhood: A Case Report
    Bahal, Mridu
    Kumar, Gaurav
    Mane, Shailaja
    Chavan, Sanjay
    Gupta, Aryan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [45] Clinical and molecular characterization of early-onset colorectal cancer
    Willauer, Alexandra N.
    Liu, Yusha
    Pereira, Allan A. L.
    Lam, Michael
    Morris, Jeffrey S.
    Raghav, Kanwal P. S.
    Morris, Van K.
    Menter, David
    Broaddus, Russell
    Meric-Bernstam, Funda
    Hayes-Jordan, Andrea
    Huh, Winston
    Overman, Michael J.
    Kopetz, Scott
    Loree, Jonathan M.
    CANCER, 2019, 125 (12) : 2002 - 2010
  • [46] A multinational study on motor function in early-onset FSHD
    Mah, Jean K.
    Feng, Jia
    Jacobs, Marni B.
    Duong, Tina
    Carroll, Kate
    de Valle, Katy
    Carty, Cara L.
    Morgenroth, Lauren P.
    Guglieri, Michela
    Ryan, Monique M.
    Clemens, Paula R.
    Thangarajh, Mathula
    Webster, Richard
    Smith, Edward
    Connolly, Anne M.
    McDonald, Craig M.
    Karachunski, Peter
    Tulinius, Mar
    Harper, Amy
    Cnaan, Avital
    Chen, Yi-Wen
    NEUROLOGY, 2018, 90 (15) : E1333 - E1338
  • [47] Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis
    Novotna, Martina
    Soldan, M. Mateo Paz
    Abou Zeid, Nuhad
    Kale, Nilufer
    Tutuncu, Melih
    Crusan, Daniel J.
    Atkinson, Elizabeth J.
    Siva, Aksel
    Keegan, B. Mark
    Pirko, Istvan
    Pittock, Sean J.
    Lucchinetti, Claudia F.
    Noseworthy, John H.
    Weinshenker, Brian G.
    Rodriguez, Moses
    Kantarci, Orhun H.
    NEUROLOGY, 2015, 85 (08) : 722 - 729
  • [48] Extended-release vinpocetine: a possible adjuvant treatment for focal onset epileptic seizures
    Garza-Morales, Saul
    Briceno-Gonzalez, Eduardo
    Ceja-Moreno, Hugo
    Ruiz-Sandoval, Jose L.
    Gongora-Rivera, Fernando
    Rodriguez-Leyva, Ildefonso
    Alonso-Rivera, Carlos G.
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2019, 76 (05): : 215 - 224
  • [49] Estimated Prevalence and Incidence of Multiple Sclerosis in Iran
    Etemadifar, Masoud
    Izadi, Sadegh
    Nikseresht, Alireza
    Sharifian, Maryam
    Sahraian, Mohammad Ali
    Nasr, Zahra
    EUROPEAN NEUROLOGY, 2014, 72 (5-6) : 370 - 374
  • [50] IL1-β expression in multiple sclerosis
    Maghzi, Amir Hadi
    Minagar, Alireza
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 343 (1-2) : 1 - 1